
Shoulder Innovations (SI) secured a $45 million debt facility in partnership with Trinity Capital. This is in addition to SI’s $42 million Series D equity financing, which closed earlier this year.
Following the launch of its InSet Shoulder Arthroplasty platform, this additional capital will bolster efforts to rapidly expand commercial and technology initiatives for the company. InSet includes the InSet Glenoid, Humeral Short Stem, Reverse and Stemless components.
Rob Ball, CEO of Shoulder Innovations said, “We’re delighted to announce this next milestone in establishing a very robust balance sheet established to support the growth of a world-class technology platform. We’re looking forward to a fruitful relationship with Trinity Capital, built upon our great accomplishments thus far.”
Sourcer: Shoulder Innovations
Shoulder Innovations (SI) secured a $45 million debt facility in partnership with Trinity Capital. This is in addition to SI’s $42 million Series D equity financing, which closed earlier this year.
Following the launch of its InSet Shoulder Arthroplasty platform, this additional capital will bolster efforts to rapidly expand commercial and...
Shoulder Innovations (SI) secured a $45 million debt facility in partnership with Trinity Capital. This is in addition to SI’s $42 million Series D equity financing, which closed earlier this year.
Following the launch of its InSet Shoulder Arthroplasty platform, this additional capital will bolster efforts to rapidly expand commercial and technology initiatives for the company. InSet includes the InSet Glenoid, Humeral Short Stem, Reverse and Stemless components.
Rob Ball, CEO of Shoulder Innovations said, “We’re delighted to announce this next milestone in establishing a very robust balance sheet established to support the growth of a world-class technology platform. We’re looking forward to a fruitful relationship with Trinity Capital, built upon our great accomplishments thus far.”
Sourcer: Shoulder Innovations
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





